Medicenna Therapeutics Stock Quote MDNA - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

0.157

Bid

0.1565

Ask

0.1612

Volume

0.00 Day's Range 0.00

0.151251 52 Week Range 0.8388

Market Cap

131.614M

Previous Close

0.157

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

69,637,000

Dividend Yield

PE Ratio

-13.10

Earnings Per Share (EPS)

-0.14

Revenue

Net Profit

-10.05M

Medicenna Therapeutics Corp is a Canada based immuno-oncology company. Its principal business activity is the development and commercialization of Empowered Cytokines and Superkines for the treatment of cancer. The company is engaged in developing Interleukin-4 Empowered Cytokines that specifically ... Medicenna Therapeutics Corp is a Canada based immuno-oncology company. Its principal business activity is the development and commercialization of Empowered Cytokines and Superkines for the treatment of cancer. The company is engaged in developing Interleukin-4 Empowered Cytokines that specifically target the Interleukin-4 Receptor which is over-expressed by 20 different cancers, cancer stem cells and immunosuppressive cells of the tumor microenvironment. The have the potential to purge the tumor and un-blind the immune system to cancer thereby altering the treatment paradigm for a large majority of cancer patients. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.medicenna.com

Headquarters

Toronto, Ontario, Can

Founded

1970

Medicenna Therapeutics Corporation is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker MDNA. The last closing price for Medicenna Therapeutics was $0.16. Over the last year, Medicenna Therapeutics shares have traded in a share price range of $ 0.151251 to $ 0.8388.

Medicenna Therapeutics currently has 69,637,000 shares outstanding. The market capitalization of Medicenna Therapeutics is $131.61 million. Medicenna Therapeutics has a price to earnings ratio (PE ratio) of -13.10.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	-0.1247	-44.2669506567	0.2817	0.2817	0.151251	765499	0.19007117	CS
52	-0.473	-75.0793650794	0.63	0.8388	0.151251	193192	0.37856297	CS
156	-3.673	-95.9007832898	3.83	4.06	0.151251	163098	1.23307134	CS
260	-4.473	-96.6090712743	4.63	6.84	0.151251	160333	1.80496231	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
ILAGIntelligent Living Application Group Inc	$ 0.725 (34.26%)	1.69M
THMOThermoGenesis Holdings Inc	$ 0.83 (27.69%)	1.25k
NUWENewellis Inc	$ 0.3199 (26.89%)	1.43M
CDTXCidara Therapeutics Inc	$ 15.21 (23.76%)	159.58k
AIREreAlpha Tech Corporation	$ 1.42 (22.41%)	2.28M
FBLGraniteShares ETF Trust GraniteShares	$ 20.72 (-22.60%)	655.51k
METAMeta Platforms Inc	$ 439.00 (-11.04%)	6.66M
INMInMed Pharmaceuticals Inc	$ 0.27 (-10.89%)	581.44k
AKLIAkili Inc	$ 0.221 (-10.89%)	5k
JAKKJAKKS Pacific Inc	$ 21.05 (-10.27%)	4.59k
SQQQProShares UltraPro Short QQQ	$ 12.1398 (2.79%)	9.04M
METAMeta Platforms Inc	$ 439.00 (-11.04%)	6.66M
HCPHashiCorp Inc	$ 32.85 (4.58%)	4.37M
CSSEChicken Soup for the Soul Entertainment Inc	$ 0.425 (-0.07%)	3.69M
QQQInvesco QQQ Trust Series 1	$ 422.55 (-0.93%)	3.4M